EP2195026
And-sklerostín-mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.9.2008EP published:
25.12.2013EP application number:
08832690.5
EP translation filed:
24.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
16.9.2028Expiry date:
16.9.2026Next due date:
30.9.2026
Title:
Anti-sclerostin antibodies
Timeline
Owner
Name:
Amgen, IncAddress:
Patent Operations, M/S 28-2-C One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
PADHI, Ian, DesmondAddress:
Newbury ParkCA, US
Name:
JANG, Graham, RichardAddress:
Santa Monica, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
973024 PDate:
17.9.2007Country:
US
Classification
Categories:
A61K 39/395, A61P 19/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.8.2014
Expires: 16.9.2015
Payer: Árnason Faktor
Number: 8
Paid: 25.8.2015
Expires: 16.9.2016
Payer: Árnason Faktor
Number: 9
Paid: 8.8.2016
Expires: 16.9.2017
Payer: Árnason Faktor
Number: 10
Paid: 9.8.2017
Expires: 16.9.2018
Payer: Árnason Faktor
Number: 11
Paid: 8.8.2018
Expires: 16.9.2019
Payer: Árnason Faktor
Number: 12
Paid: 7.8.2019
Expires: 16.9.2020
Payer: Árnason Faktor
Number: 13
Paid: 6.8.2020
Expires: 16.9.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.8.2021
Expires: 16.9.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 16.8.2022
Expires: 16.9.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 31.8.2023
Expires: 16.9.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.8.2024
Expires: 16.9.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 15.9.2025
Expires: 16.9.2026
Payer: Árnason Faktor ehf.